Author

Xia Feng

First Affiliated Hospital of Nanchang UniversityPrimary ORCID profile (0000-0002-6074-9254 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Xia FengiD1 paper · Zhejiang University

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Fan Xia· 1 shared Shaolin GongiD· 1 shared Xiang WangiD· 1 shared Xiaoping PengiD· 1 shared Xiaoting Jiang· 1 shared Yaguang BiiD· 1 shared Yongnan Fu· 1 shared Zhiping Xiong· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Fan Xia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Isoliensinine Ameliorates Pathological Cardiac Hypertrophy After Aerobic Exercise by Activating Cytochrome c Oxidase Subunit 6A2

Shaolin Gong, Xia Feng, Xiaoting Jiang, Yaguang Bi, Fan Xia, Yongnan Fu, Xiaoping Peng, Zhiping Xiong, Xiang Wang

This study identifies isoliensinine's role in improving cardiac function by enhancing COX6A2 expression through swimming exercise, revealing a novel signaling axis in pathological cardiac hypertrophy.

bioRxiv · Jul 7, 2025 · PreprintMolecular Biology